ATM and breast cancer: Anti-ATM antibody ab32420 identified ATM loss or reduction in 616 of 1183 (52%) and ATM high in 567 of 1183 (48%) breast cancers and ATM loss or reduction was associated with poor survival in estrogen receptor negative breast cancer [34].